Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS)
Author(s) -
Marco A. Costa,
Ronald G. Carere,
Samuel V. Lichtenstein,
David P. Foley,
Vincent de Valk,
Wietze Lindenboom,
P. Roose,
Theo R. van Geldorp,
Carlos Macaya,
José L. Casta,
Francisco Fernandez-Avilèz,
Jesús Herreros Gonzáles,
Günter Heyer,
Felix Unger,
Patrick W. Serruys
Publication year - 2001
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/hc4701.099789
Subject(s) - medicine , cardiology , myocardial infarction , perioperative , revascularization , percutaneous coronary intervention , incidence (geometry) , population , bypass surgery , surgery , artery , optics , environmental health , physics
Although it has been suggested that elevation of CK-MB after percutaneous coronary intervention is associated with adverse clinical outcomes, limited data are available in the setting of coronary bypass grafting. The aim of the present study was to determine the incidence, predictors, and prognostic significance of CK-MB elevation following multivessel coronary bypass grafting (CABG).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom